Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Case report

A case of masked toxic adenoma in a patient with non-thyroidal illness

Authors: Eun Ae Cho, Jee Hee Yoon, Hee Kyung Kim, Ho-Cheol Kang

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Non-thyroidal illness (NTI) refers to changes in thyroid hormone levels in critically ill patients in the absence of primary hypothalamic-pituitary-thyroid dysfunction, and these abnormalities usually resolve after clinical recovery. However, NTI can be accompanied by primary thyroid dysfunction. We report herein a case of a woman with NTI accompanied by primary hyperthyroidism.

Case presentation

A 52-year-old female was admitted to the intensive care unit with heart failure and atrial fibrillation. She had a longstanding thyroid nodule, and a thyroid function test revealed low levels of triiodothyronine and free thyroxine as well as undetectable thyroid stimulating hormone (TSH). She was diagnosed with NTI, and her TSH level began to recover but not completely at discharge. The thyroid function test was repeated after 42 months to reveal primary hyperthyroidism, and a thyroid scan confirmed a toxic nodule.

Conclusion

This case suggests that although NTI was diagnosed, primary hyperthyroidism should be considered as another possible diagnosis if TSH is undetectable. Thyroid function tests should be repeated after clinical recovery from acute illness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Melmed SPK, Larsen PR, Kronenberg HM: Williams Textbook of Endocrinology. 2011, Philadelphia, PA: Saunders Elsevier, 327-405. 12 Melmed SPK, Larsen PR, Kronenberg HM: Williams Textbook of Endocrinology. 2011, Philadelphia, PA: Saunders Elsevier, 327-405. 12
2.
go back to reference Bermudez F, Surks MI, Oppenheimer JH: High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1975, 41 (1): 27-40. 10.1210/jcem-41-1-27.CrossRefPubMed Bermudez F, Surks MI, Oppenheimer JH: High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1975, 41 (1): 27-40. 10.1210/jcem-41-1-27.CrossRefPubMed
3.
go back to reference Adler SM, Wartofsky L: The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007, 36 (3): 657-672. 10.1016/j.ecl.2007.04.007. viCrossRefPubMed Adler SM, Wartofsky L: The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am. 2007, 36 (3): 657-672. 10.1016/j.ecl.2007.04.007. viCrossRefPubMed
4.
go back to reference De Marinis L, Mancini A, Masala R, Torlontano M, Sandric S, Barbarino A: Evaluation of pituitary-thyroid axis response to acute myocardial infarction. J Endocrinol Invest. 1985, 8 (6): 507-511.CrossRefPubMed De Marinis L, Mancini A, Masala R, Torlontano M, Sandric S, Barbarino A: Evaluation of pituitary-thyroid axis response to acute myocardial infarction. J Endocrinol Invest. 1985, 8 (6): 507-511.CrossRefPubMed
5.
go back to reference De Groot LJ: Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84 (1): 151-164. 10.1210/jc.84.1.151.CrossRefPubMed De Groot LJ: Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999, 84 (1): 151-164. 10.1210/jc.84.1.151.CrossRefPubMed
6.
go back to reference Ray DC, Drummond GB, Wilkinson E, Beckett GJ: Relationship of admission thyroid function tests to outcome in critical illness. Anaesthesia. 1995, 50 (12): 1022-1025. 10.1111/j.1365-2044.1995.tb05943.x.CrossRefPubMed Ray DC, Drummond GB, Wilkinson E, Beckett GJ: Relationship of admission thyroid function tests to outcome in critical illness. Anaesthesia. 1995, 50 (12): 1022-1025. 10.1111/j.1365-2044.1995.tb05943.x.CrossRefPubMed
7.
go back to reference Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L: Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003, 107 (5): 708-713. 10.1161/01.CIR.0000048124.64204.3F.CrossRefPubMed Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L: Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003, 107 (5): 708-713. 10.1161/01.CIR.0000048124.64204.3F.CrossRefPubMed
8.
go back to reference Iglesias P, Munoz A, Prado F, Guerrero MT, Macias MC, Ridruejo E, Tajada P, Diez JJ: Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol (Oxf). 2009, 70 (6): 961-967. 10.1111/j.1365-2265.2008.03421.x.CrossRef Iglesias P, Munoz A, Prado F, Guerrero MT, Macias MC, Ridruejo E, Tajada P, Diez JJ: Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol (Oxf). 2009, 70 (6): 961-967. 10.1111/j.1365-2265.2008.03421.x.CrossRef
9.
go back to reference Mebis L, Van den Berghe G: Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab. 2011, 25 (5): 745-757. 10.1016/j.beem.2011.03.002.CrossRefPubMed Mebis L, Van den Berghe G: Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab. 2011, 25 (5): 745-757. 10.1016/j.beem.2011.03.002.CrossRefPubMed
10.
go back to reference Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Scholmerich J, Wrede CE: Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism. 2007, 56 (2): 239-244. 10.1016/j.metabol.2006.09.020.CrossRefPubMed Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Scholmerich J, Wrede CE: Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism. 2007, 56 (2): 239-244. 10.1016/j.metabol.2006.09.020.CrossRefPubMed
11.
go back to reference Wartofsky L, Burman KD, Ringel MD: Trading one “dangerous dogma” for another? Thyroid hormone treatment of the “euthyroid sick syndrome”. J Clin Endocrinol Metab. 1999, 84 (5): 1759-1760. 10.1210/jc.84.5.1759.PubMed Wartofsky L, Burman KD, Ringel MD: Trading one “dangerous dogma” for another? Thyroid hormone treatment of the “euthyroid sick syndrome”. J Clin Endocrinol Metab. 1999, 84 (5): 1759-1760. 10.1210/jc.84.5.1759.PubMed
12.
go back to reference Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J: Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem. 1987, 33 (8): 1391-1396.PubMed Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J: Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem. 1987, 33 (8): 1391-1396.PubMed
13.
go back to reference Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D, Nicoloff JT: Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990, 70 (2): 453-460. 10.1210/jcem-70-2-453.CrossRefPubMed Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D, Nicoloff JT: Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990, 70 (2): 453-460. 10.1210/jcem-70-2-453.CrossRefPubMed
14.
go back to reference Attia J, Margetts P, Guyatt G: Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med. 1999, 159 (7): 658-665. 10.1001/archinte.159.7.658.CrossRefPubMed Attia J, Margetts P, Guyatt G: Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med. 1999, 159 (7): 658-665. 10.1001/archinte.159.7.658.CrossRefPubMed
15.
go back to reference Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT: Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab. 1980, 51 (2): 387-393. 10.1210/jcem-51-2-387.CrossRefPubMed Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT: Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab. 1980, 51 (2): 387-393. 10.1210/jcem-51-2-387.CrossRefPubMed
16.
go back to reference Lee E, Chen P, Rao H, Lee J, Burmeister LA: Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol (Oxf). 1999, 50 (4): 487-492. 10.1046/j.1365-2265.1999.00678.x.CrossRef Lee E, Chen P, Rao H, Lee J, Burmeister LA: Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH). Clin Endocrinol (Oxf). 1999, 50 (4): 487-492. 10.1046/j.1365-2265.1999.00678.x.CrossRef
17.
go back to reference Nicoloff JT, Fisher DA, Appleman MD: The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 1970, 49 (10): 1922-1929. 10.1172/JCI106411.CrossRefPubMedPubMedCentral Nicoloff JT, Fisher DA, Appleman MD: The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 1970, 49 (10): 1922-1929. 10.1172/JCI106411.CrossRefPubMedPubMedCentral
18.
go back to reference Colao A, Merola B, Ferone D, Marzullo P, Cerbone G, Longobardi S, Di Somma C, Lombardi G: Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas. Eur J Endocrinol. 1995, 133 (2): 189-194. 10.1530/eje.0.1330189.CrossRefPubMed Colao A, Merola B, Ferone D, Marzullo P, Cerbone G, Longobardi S, Di Somma C, Lombardi G: Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas. Eur J Endocrinol. 1995, 133 (2): 189-194. 10.1530/eje.0.1330189.CrossRefPubMed
19.
go back to reference Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993, 365 (6447): 649-651. 10.1038/365649a0.CrossRefPubMed Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993, 365 (6447): 649-651. 10.1038/365649a0.CrossRefPubMed
20.
go back to reference Hegedus L, Bonnema SJ, Bennedbaek FN: Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003, 24 (1): 102-132. 10.1210/er.2002-0016.CrossRefPubMed Hegedus L, Bonnema SJ, Bennedbaek FN: Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003, 24 (1): 102-132. 10.1210/er.2002-0016.CrossRefPubMed
Metadata
Title
A case of masked toxic adenoma in a patient with non-thyroidal illness
Authors
Eun Ae Cho
Jee Hee Yoon
Hee Kyung Kim
Ho-Cheol Kang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-1

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue